Press Releases :: Nighthawk Biosciences, Inc. (SCPX)

May 06, 2019 7:00am EDT

Heat Biologics Lead Director to Present at the ChinaBio 2019 Conference in Shanghai

Apr 18, 2019 5:30pm EDT

Heat Biologics CEO to Present at the ThinkEquity Conference in New York City

Apr 02, 2019 8:00am EDT

Heat Biologics Delivers Poster Presentation at the AACR Annual Meeting 2019

Mar 28, 2019 7:30am EDT

Heat Biologics Reports 2018 Results and Provides Corporate Update

Mar 21, 2019 7:00am EDT

Heat Biologics to Present at the Chinese Society for Clinical Oncology Conference on Immunotherapy

Mar 05, 2019 9:25am EST

Heat Biologics Lead Director to Chair Oncology Roundtable Discussion at WuXi Healthcare Forum in Shanghai

Feb 28, 2019 5:00pm EST

Heat Biologics Presents Interim Phase 2 Lung Cancer Data on HS-110 + Nivolumab at ASCO-SITC Clinical Immuno-Oncology Symposium

Jan 14, 2019 2:15pm EST

UPDATE: Heat Biologics Doses First Patient in New Cohort of its Expanded Phase 2 Trial of HS-110 in Combination with Merck's KEYTRUDA(R) in Non-Small Cell Lung Cancer Trial

Jan 14, 2019 8:00am EST

Heat Biologics Doses First Patient in New Cohort of its Expanded Phase 2 Trial of HS-110 in Combination with Merck's KEYTRUDA(R) in Non-Small Cell Lung Cancer Trial

Jan 10, 2019 7:30am EST

Heat Biologics Provides Clinical and Business Update

rss_feed News RSS